Company Profile

Quadrant Biosciences Inc (AKA: Motion Intelligence Inc)
Profile last edited on: 3/15/21      CAGE: 7HPB2      UEI: SBLLARCRNMM1

Business Identifier: Diagnostic tools for concussions & austism
Year Founded
2015
First Award
2016
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

505 Irving Avenue STE 3100AB
Syracuse, NY 13210
   (607) 227-4400
   N/A
   www.quadrantbiosciences.com
Location: Single
Congr. District: 24
County: Onondaga

Public Profile

Motion Intelligence works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications. The firm's two evolutionary advancements in concussion assessment and autism detection could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, these key technologies will be available in market in 2016.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $380,848
Project Title: Refinement of a Rapid Saliva Mirna Diagnostic Test for Concussion
2020 2 NIH $2,470,565
Project Title: Validation of a salivary miRNA diagnostic test for autism spectrum disorder

Key People / Management

  Benjamin Perry -- President

  Richard Uhlig -- Founder and CEO

  Gregory R Fedorchak

  David MacLean -- Chief Marketing Officer

  Frank A Middleton

  Jeremy Williams -- Chief Technology Officer

Company News

There are no news available.